{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:37:25Z","timestamp":1790739445474,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/mt.2015.149","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T07:58:07Z","timestamp":1439798287000},"page":"184-192","source":"Crossref","is-referenced-by-count":16,"title":["The Role of Neutrophils in Measles Virus\u2013mediated Oncolysis Differs Between B-cell Malignancies and Is Not Always Enhanced by GCSF"],"prefix":"10.1016","volume":"24","author":[{"given":"Aditi","family":"Dey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Z","family":"Castleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Beaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele K","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.149_bib1","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V97.12.3746","article-title":"Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice","volume":"97","author":"Grote","year":"2001","journal-title":"Blood"},{"key":"10.1038\/mt.2015.149_bib2","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/mt.2011.44","article-title":"Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insights","volume":"19","author":"Patel","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.149_bib3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.mayocp.2014.04.003","article-title":"Remission of disseminated cancer after systemic oncolytic virotherapy","volume":"89","author":"Russell","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/mt.2015.149_bib4","first-page":"6463","article-title":"Neutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expression","volume":"63","author":"Grote","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.149_bib5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4049\/jimmunol.1102262","article-title":"Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil function","volume":"188","author":"Zhang","year":"2012","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.149_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.V97.2.339","article-title":"The intriguing role of polymorphonuclear neutrophils in antitumor reactions","volume":"97","author":"Di Carlo","year":"2001","journal-title":"Blood"},{"key":"10.1038\/mt.2015.149_bib7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4049\/jimmunol.171.3.1183","article-title":"Fas ligand on tumor cells mediates inactivation of neutrophils","volume":"171","author":"Chen","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.149_bib8","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood-2005-03-1327","article-title":"Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL\/Apo-2L","volume":"106","author":"Kemp","year":"2005","journal-title":"Blood"},{"key":"10.1038\/mt.2015.149_bib9","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/sj.mt.6300215","article-title":"Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow","volume":"15","author":"Breitbach","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.149_bib10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/mt.2011.26","article-title":"Targeting tumor vasculature with an oncolytic virus","volume":"19","author":"Breitbach","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.149_bib11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/mt.2012.4","article-title":"Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus","volume":"20","author":"Iankov","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.149_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood.V75.1.17.17","article-title":"Granulocyte colony-stimulating factor stimulates human mature neutrophilic granulocytes to produce interferon-alpha","volume":"75","author":"Shirafuji","year":"1990","journal-title":"Blood"},{"key":"10.1038\/mt.2015.149_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0167-5699(87)90140-X","article-title":"Why do hemopoietic growth factor receptors interact with each other?","volume":"8","author":"Nicola","year":"1987","journal-title":"Immunol Today"},{"key":"10.1038\/mt.2015.149_bib14","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1128\/JVI.72.9.7420-7427.1998","article-title":"Measles virus spread and pathogenesis in genetically modified mice","volume":"72","author":"Mrkic","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.149_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cytogfr.2014.07.011","article-title":"G-CSF: from granulopoietic stimulant to bone marrow stem cell mobilizing agent","volume":"25","author":"Bendall","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1038\/mt.2015.149_bib16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0006-291X(87)90296-8","article-title":"Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF)","volume":"142","author":"Tamura","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2015.149_bib17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/leu.2011.76","article-title":"Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist","volume":"25","author":"Parameswaran","year":"2011","journal-title":"Leukemia"},{"key":"10.1038\/mt.2015.149_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.exphem.2012.11.004","article-title":"Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice","volume":"41","author":"Welschinger","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1038\/mt.2015.149_bib19","author":"Uy","year":"2013","journal-title":"Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia"},{"key":"10.1038\/mt.2015.149_bib20","article-title":"Effects of G-CSF on acute lymphoblastic leukemia. 2564 (54th ASH annual meeting and exposition","author":"Basnett","year":"2012","journal-title":"American Society of Hematology Atlanta, GA"},{"key":"10.1038\/mt.2015.149_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1607","article-title":"Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML","volume":"28","author":"Saito","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2015.149_bib22","first-page":"1497","article-title":"Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation","volume":"23","author":"Shimazaki","year":"1995","journal-title":"Exp Hematol"},{"key":"10.1038\/mt.2015.149_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2013-09-528851","article-title":"Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity","volume":"123","author":"Castleton","year":"2014","journal-title":"Blood"},{"key":"10.1038\/mt.2015.149_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0166-0934(03)00132-0","article-title":"Enhanced genetic rescue of negative-strand RNA viruses: use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors","volume":"111","author":"Kovacs","year":"2003","journal-title":"J Virol Methods"},{"key":"10.1038\/mt.2015.149_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1525-0016(02)00033-3","article-title":"An oncolytic measles virus engineered to enter cells through the CD20 antigen","volume":"7","author":"Bucheit","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.149_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-3565(25)21074-6","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human granulocyte-colony stimulating factor after intravenous and subcutaneous administration in the rat","volume":"251","author":"Tanaka","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/mt.2015.149_bib27","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/aws054","article-title":"Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease","volume":"135","author":"Frank","year":"2012","journal-title":"Brain"},{"key":"10.1038\/mt.2015.149_bib28","doi-asserted-by":"crossref","first-page":"PL163","DOI":"10.1016\/S0024-3205(98)00038-1","article-title":"Influence of dosing time on pharmacological action of G-CSF in mice","volume":"62","author":"Ohdo","year":"1998","journal-title":"Life Sciences"},{"key":"10.1038\/mt.2015.149_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.phrs.2003.12.011","article-title":"Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model","volume":"50","author":"Kotto-Kome","year":"2004","journal-title":"Pharmacol Res"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T20:57:10Z","timestamp":1748552230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616303203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1525001616303203"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.149","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}